Related Experiment Videos
[Antithrombin III: its prognostic value in acute pancreatitis]
G Las Heras1, F J Roncalés, J Juncà
1Servicio de Hematología y Hemoterapia, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona.
Sangre
|June 1, 1992
Summary
Antithrombin III (AT-III) levels can predict acute pancreatitis severity. Low AT-III activity, especially under 70% in the first week, indicates a serious prognosis in acute pancreatitis patients.
Area of Science:
- Biochemistry
- Clinical Medicine
- Prognostic Biomarkers
Context:
- Acute pancreatitis (AP) is a serious condition with variable outcomes.
- Early identification of severe AP is crucial for timely intervention.
- Antithrombin III (AT-III) is a key regulator of coagulation.
Purpose:
- To evaluate Antithrombin III (AT-III) activity as a prognostic factor in acute pancreatitis (AP).
- To determine if AT-III levels can aid in the early detection of negative evolution in AP patients.
Summary:
- AT-III levels were monitored in 28 AP patients over six months.
- Lower AT-III activity (<80%) was observed in serious AP cases up to day 10, while non-serious cases maintained normal levels.
- A significant difference in AT-III evolution was noted between serious and non-serious AP, particularly within the first week and in fatal cases.
Impact:
- AT-III determination serves as a valuable prognostic tool for differentiating serious from non-serious acute pancreatitis.
- Levels below 70% AT-III activity within the first week are indicative of a poorer prognosis.
- This finding supports the use of AT-III as an early predictive marker in AP management.